On-Demand: Physician Views: Developing Treatments for NASH

June 28, 2018

Several drug companies are developing treatments for Non-alcoholic Steatohepatitis (NASH). We recently surveyed US physicians to find out how they are treating patients and comorbid conditions—and what they would like to see in a regimen.

In this on-demand webinar we hear Molly Simpson, InCrowd’s Director for Client Engagement, discuss the key findings.

Watch now!

    InCrowd uses the information you provide to us to contact you about our relevant insights, products, and services. You may opt out of communications at any time via the unsubscribe link at the bottom of any email or by sending an email withdrawing your consent to Send Email. For more information, please review our Privacy Policy.
  • This field is for validation purposes and should be left unchanged.